Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.
about
Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseCognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum.How I manage cerebral vasculopathy in children with sickle cell disease.Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell AnemiaUnderstanding sickle cell brain drain.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.Pediatric sickle cell disease: past successes and future challenges.Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease.Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohorts.In Vivo T1 of Blood Measurements in Children with Sickle Cell Disease Improve Cerebral Blood Flow Quantification from Arterial Spin-Labeling MRI.Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority triaSickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment.Nocturnal oxyhemoglobin desaturation and arteriopathy in a pediatric sickle cell disease cohort.Transcranial Doppler in autonomic testing: standards and clinical applications.Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy.Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.Stroke recurrence in adult sickle cell patients: it is time for action!
P2860
Q24202463-79FD447D-AB71-4067-995A-A3459A415893Q30691983-7AF0724D-BEEF-4B9F-BDA7-6A82CF51302AQ30945117-0B0DC7E2-DFDE-46C5-A005-40A8F04EEF3CQ33679897-D93888B6-79E6-4EBD-8E82-E5867145392BQ33808268-49D0EC09-ED46-45DB-9221-C24B9B520B33Q34019554-B0DDF593-8833-41C9-BD11-2EF6EE9AC1C1Q36251052-A529FA09-9F05-45C9-82EF-41318B4B3A0EQ36370980-ADC85025-6949-4D4C-851A-980AC483ED97Q36470425-D0C994C0-415A-4151-9327-D77E578E8867Q37285132-871B1AF9-8E8C-4E0E-93D2-9D5DC6AE514FQ38814652-E323B48F-C659-4417-B3B6-2B534A2217B2Q39412777-6F36BF61-44B8-4D1A-A21A-9DA5C2419425Q41683705-0C24DCF8-6F53-4B70-8C1B-38BF9C5E2C24Q41719695-A6FEAD56-FDC2-46B9-BEC2-8C1DD4B8D1A0Q42505511-1440F145-B448-4EB7-A50B-E1D4313C90E4Q42514544-A41CA76B-57D6-4B44-82A2-2E5F2D81171BQ43723150-A95F452F-1530-4CC6-A1A5-8AAC355E89BBQ45953571-EA46C323-9391-460C-BE24-6C87A56CC172Q45984850-F758B482-A16E-4903-BAAC-C437E2D5F78BQ47100582-4B3ED4AE-68EE-4329-84E4-4EDFDD33BE0FQ47414741-72B61763-B538-4DA5-A2DE-B1D15FED757FQ47424061-A982F702-76E7-49D7-A10C-CF0CFFFB94C3Q48148524-1475C792-592D-4443-B6DF-078295B09CBEQ48325325-2F64BC35-9271-4C8A-8BA4-F2813150B220Q52726275-7B754FE9-DA21-49B3-857B-E6433C746A3FQ53102076-86A7CF7E-E26D-4571-8178-D7310F10F9B4
P2860
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@ast
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@en
type
label
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@ast
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@en
prefLabel
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@ast
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@en
P2093
P2860
P1433
P1476
Magnetic resonance imaging/ang ...... results from the SWiTCH trial.
@en
P2093
Alex Lockhart
Banu Aygun
Catherine Driscoll
Karen L Kesler
Kathleen J Helton
Lakshmanan Krishnamurti
Matthew M Heeney
Robert J Adams
Russell E Ware
SWiTCH Investigators
P2860
P304
P356
10.1182/BLOOD-2013-12-545186
P407
P577
2014-06-09T00:00:00Z